Even with the highest step of standardized treatment, in which targeted therapies like anti-IgE, anti-IL5, anti-IL5R, and anti-IL4R antibodies would be applied, uncontrolled asthma symptoms and exacerbation still frequently exist in some patients (Israel and Reddel, 2017; Chipps et al., 2018). Here, IGHE is linked to asthma.